pipette
ESEspañol

Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition

Wenxin Hu, Honglin Chen, Steven He, Joshua M. L. Casan, Carolyn Shembrey, Sharon Li, Lauren M. Brown, Andrea Zhao, Lynda Truong, Isabella Buchner, Dane Vassiliadis, Timothy P. Hughes, Deborah L. White, Catherine Carmichael, Antoine de Weck, Ilia Voskoboinik, Quentin A. Gouil, Joseph A. Trapani, Paul G. Ekert, Teresa Sadras, Mohamed Fareh

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Here, we establish CRISPR- Psp Cas13b as a personalizable platform for systematic silencing of various fusion transcripts.

Appeared: Sunday, October 18. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.ady0296